A group of dentistry researchers in Japan, whose work on stem cells has been the subject of an institutional investigation, have now lost two papers in PLOS ONE for image problems. The authors, from Aichi Gakuin University in Nagoya, were led by Makio Mogi, a medicinal biochemist at the school. Mogi asked for at least … Continue reading Stem cell researchers have papers retracted for image manipulation
A journal has allowed a group of researchers in Italy to correct a 2016 paper with questionable images after a faculty member in their institution — and a frequent co-author of the group’s — said his investigation found no reason to doubt their integrity. The article, “Arg tyrosine kinase modulates TGF-β1 production in human renal … Continue reading No ‘possible fraudulent explanation’: Frequent co-author tasked with clearing colleagues of image manipulation
Harvard has investigated work from the lab of a cancer researcher at Beth Israel Deaconess Medical Center that has been under scrutiny on PubPeer for more than five years. Questions about the output of the lab, run by James W. Mier, began appearing on PubPeer in 2014, with comments about images that looked manipulated. The … Continue reading Cancer lab at Harvard subject of inquiry
A researcher in India is up to five retractions, by our count, for problematic data and image issues. The latest retractions involve articles published in 2008 and 2013 in the journal Life Sciences. The last author on the papers is Yogeshwer Shukla, of the Council of Scientific and Industrial Research, about whom we have previously … Continue reading Cancer researcher up to five retractions
Should journals always take authors at their word? Take the case of a recent expression of concern in the Journal of Cell Science following concerns about image manipulation in a 2006 paper, “Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes.” Here’s the notice:
Retraction Watch readers may know the name Elisabeth Bik, whose painstaking work inspecting tens of thousands of Western blot images has led to dozens of retractions in journals including PLOS ONE. Today in The Scientist, we profile Bik, a microbiologist who calls herself a “super-introvert.” Bik tells us:
A group of researchers at Harbin Medical University in China has had a third paper retracted, making for a tale of three notices. The first retraction appeared in April 2017 as one of more than 100 from Tumor Biology for fake peer review. The second, for “Functions as a Tumor Suppressor in Osteosarcoma by Targeting … Continue reading Group in China up to three retractions, ostensibly for three different reasons
We have news of two upcoming retractions, both following critiques on PubPeer. PLOS ONE is retracting a 2012 paper by researchers at the Istituto Superiore di Sanità in Rome and the World Health Organization’s International Agency for Research on Cancer in Lyon, France, “Interferon-β Induces Cellular Senescence in Cutaneous Human Papilloma Virus-Transformed Human Keratinocytes by … Continue reading “All very painful:” Two retractions to watch for, in eLife and PLOS ONE
A researcher who studied natural products for cancer at the University of Alabama, Birmingham (UAB), had six papers retracted last month, bringing him to a total of 12. Four of the recently retracted papers by Santosh Katiyar had appeared in PLOS ONE, and two had been published in Cancer Research. They have together been cited … Continue reading Former UAB natural products researcher up to a dozen retractions
A Washington University researcher has admitted to committing research misconduct in research involving eight U.S. government grants, according to a Federal watchdog, and resigned his position, according to the university. Srikanth Santhanam, a staff scientist in the department of internal medicine’s division of gastroenterology at Washington University in St. Louis, “voluntarily admitted to engaging in … Continue reading Wash U scientist admits to research misconduct, resigns post